GH Guardant Health: Prakiraan wutah bathi kanggo taun ngarep

The EPS growth trajectory for next year confirms the pricing power potential of Guardant Health, Inc. (GH) driven by its unique early-stage cancer tests. The implementation of robotic DNA sequencing systems is accelerating diagnostics, while adherence to ESG standards minimizes the environmental footprint of the laboratories. The value of 34.80 characterizes this valuation parameter, capturing current analyst expectations for future stock returns.

Guardant Health Inc (GH): Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep saka 04.07.2022 nganti 13.11.2026

Rincian analitis lan laporan data perusahaan guardanthealth.com (GH)

- rega lan prakiraan konsensus rega:

Bagan rega Guardant360|GH - Target median analis

- data kapitalisasi saham perusahaan:

Kapitalisasi pasar Guardant Health|GH - Rega Tumbas Perusahaan

- indikator kapitalisasi buku:

Aset Bersih saben Siji Saham Guardant Health|GH - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku guardanthealth.com|GH - Aset Neraca Perusahaan

- data utang lan likuiditas:

Rasio Total Utang marang Ekuitas Guardant Health, Inc.|GH - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Guardant Health|GH - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Guardant Health|GH - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Guardant Health|Rasio cepet guardanthealth.com

- data bathi resik lan rasio valuasi:

GH - Bathi resik|Bathi sing dikarepake Guardant Health, Inc.|GH - Pangali rega marang bathi|Prakiraan rega marang bathi Guardant Health, Inc.|GH - Rasio nilai perusahaan marang wutah bathi|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Guardant Health|GH - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Guardant Health|GH - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan guardanthealth.com|GH - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Guardant Health, Inc.

Analisis dhasar perusahaan:GH, Guardant360

The consensus earnings growth forecast for the upcoming period measures the expected change in EPS, allowing investors to isolate the fundamental trend from market noise. This projected net income trajectory reflects the capitalization of future successes for Guardant Health, Inc. (GH), where earnings growth potential depends directly on the efficiency of scaling high-tech laboratories and optimizing costs through the digitalization of reporting.

Analisis pesaing Guardant Health, Inc.